Virbac: agreements to acquire Globion in India
(CercleFinance.com) - Virbac today announces the signature of an agreement for the acquisition of Globion, an Indian specialist in the fast-growing poultry vaccine market, a transaction that will strengthen the French group's position as market leader in animal health in India.
Founded in 2005, Globion has developed solid expertise in the development, manufacture and marketing of live and inactivated vaccines targeting a wide range of avian pathogens.
Globion is based in Hyderabad, where its industrial and R&D facilities employ around 120 full-time staff and generate annual revenues of around E12m. It is independently managed by a team of professionals.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Founded in 2005, Globion has developed solid expertise in the development, manufacture and marketing of live and inactivated vaccines targeting a wide range of avian pathogens.
Globion is based in Hyderabad, where its industrial and R&D facilities employ around 120 full-time staff and generate annual revenues of around E12m. It is independently managed by a team of professionals.
Copyright (c) 2023 CercleFinance.com. All rights reserved.